Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Fluid Therapy for Hypernatremic Dehydration in Children With Diarrhoea
NCT07884747Enrolling by invitation
- Sponsor
- icddr,b
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of low osmolar oral rehydration salts in hypernatremia and diarrhea (2 arms), sponsored by icddr,b. Primary endpoint: All-cause mortality from initiation of the intervention until hospital discharge at 7 days. Started Jan 2026; status: enrolling by invitation.
02
Drugs
low osmolar oral rehydration salts
03
Conditions
hypernatremiadiarrhea
Beyond the preview
Go deeper on NCT07884747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07884747.